Guerbet
19.70
22-May-25 08:29:59
15 minutes delayed
Stocks
-0.45
-2.23%
Today's range
19.66 - 19.86
ISIN
FR0000032526
Source
Cboe
-
Guerbet: Revenue at September 30, 2021
21 Oct 2021 08:46:04 By Nasdaq GlobeNewswire
-
29 Sep 2021 09:00:54 By Nasdaq GlobeNewswire
-
Guerbet: 2021 half-year results
22 Sep 2021 08:54:05 By Nasdaq GlobeNewswire
-
Guerbet: Revenue at June 30, 2021
22 Jul 2021 08:46:33 By Nasdaq GlobeNewswire
-
Marc Massiot appointed to Guerbet’s Board of Directors
31 May 2021 09:00:00 By Nasdaq GlobeNewswire
-
22 Apr 2021 08:45:00 By Nasdaq GlobeNewswire
-
Guerbet: Additional information related to 2021 financial outlook
28 Mar 2021 23:25:59 By Nasdaq GlobeNewswire
-
24 Mar 2021 09:45:00 By Nasdaq GlobeNewswire
-
Guerbet: Gadopiclenol - positive results for Phase III clinical trials
24 Mar 2021 00:00:00 By Nasdaq GlobeNewswire
-
11 Feb 2021 08:45:00 By Nasdaq GlobeNewswire